PAR-21-045 - Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 3

Active NOSIs
Expired NOSIs

Active NOSIs

Title	Notice Number	Organization	Release Date	Expiration Date	Activity Code(s)
Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening	NOT-OD-22-179	ODP , NIA , NIAAA , NIAMS , NICHD , NIDA , NIDCD , NIDCR , NIMH , NIMHD , NINDS , NINR , ODS , ORWH , SGMRO	Jul 14, 2022	May 8, 2025	R21, R01, R61/R33, UG3/UH3, R34, U01
Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening	NOT-OD-22-107	ODP , NIA , NIAAA , NIAMS , NICHD , NIDA , NIDCD , NIDCR , NIMH , NIMHD , NINDS , NINR , ODS , ORWH , SGMRO	May 12, 2022	May 8, 2025	333, R01, R34, R21, R61/R33, U01, UG3/UH3

Expired NOSIs

Title	Notice Number	Organization	Release Date	Expiration Date	Activity Code(s)
Notice of Special Interest (NOSI): Promoting Pain Research Within the NIAMS Mission Areas	NOT-AR-22-007	NIAMS	Sep 23, 2021	Jan 10, 2023	R01, R21, R15, R33, R13, R34, K99/R00, K24, K01, K25, K23, K08, 332